← All patents

US9937156B2

Modulation of MRTF-A activity in pathologic fibrosis and wound healing

University of Texas System

Abstract

The present disclosure concerns uses for isoxazole compounds or salts or analogs thereof for the treatment of wounds. The present disclosure also concerns devices for delivering a isoxazole compound or salts or an analogs thereof to a wound site.

University
University of Texas System
Assignee
The Board Of Regents Of The University Of Texas System
Inventor
Eric M. SMALL
Priority date
October 16, 2013
Filing date
October 16, 2014
Grant date
April 10, 2018
Publication date
April 10, 2018
Language
en
Metadata fetched
August 29, 2026 00:26